Thrombotic Events Develop in 1 Out of 5 Patients Receiving ECMO Support: An 11-Year Referral Centre Experience.
Zoran BukumiricRobert BreitkopfChristopher Duane RuggZoran BukumiricJakob ReitbauerBenedikt TremlPublished in: Journal of clinical medicine (2023)
ECMO is a specialized life-support modality with a high risk of complications. A longer ECMO duration is associated with thrombosis occurrence in patients receiving ECMO support. Following hemorrhage, thromboembolic complications are common adverse events. However, in contrast to major bleeding, no impact on mortality was observed. The question arises if a protocol with less anticoagulation may have a role to play in the future.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- atrial fibrillation
- risk factors
- mechanical ventilation
- randomized controlled trial
- primary care
- risk assessment
- cardiovascular events
- pulmonary embolism
- magnetic resonance imaging
- type diabetes
- current status
- coronary artery disease
- contrast enhanced